Vercalsteren, Ellen http://orcid.org/0000-0002-9425-4209
Karampatsi, Dimitra
Buizza, Carolina
Nyström, Thomas
Klein, Thomas
Paul, Gesine
Patrone, Cesare http://orcid.org/0000-0003-0470-4606
Darsalia, Vladimer http://orcid.org/0000-0002-6693-934X
Funding for this research was provided by:
Swedish Stroke Foundation
Foundation for Geriatric Diseases at Karolinska Institutet (2022-01273)
Ulla Hamberg Angeby och Lennart Angebys Stiftelse
Swedish Heart-Lung Foundation
ALF Stockholm (951953)
FANG Foundation and Hjärnfonden/The Swedish Brain Foundation
Swedish Medical Research Council (2022-00577)
Karolinska Institute
Article History
Received: 2 October 2023
Accepted: 19 February 2024
First Online: 29 February 2024
Declarations
:
: This study was conducted according to the guidelines of the declaration of Helsinki and has been approved by the regional ethics committee of Karolinska Institutet (approval ID: 1126). The work follows the 2010/63/EU directive and is reported according to the ARRIVE guidelines [CitationRef removed].
: All authors have declared their consent for this publication.
: This study was supported by Boehringer Ingelheim Pharma GmbH & Co. KG. TK is an employee of Boehringer Ingelheim Pharma GmbH & Co. KG. T.N. has received unrestricted grants from AstraZeneca and consultancy fees from Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Merck and Sanofi-Aventis. The other authors declare that they have no competing interests.